CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway

This publication has 25 references indexed in Scilit:

• Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: Potential regulation by ligand-dependent degradation and HIF-1α
  Biochemical and Biophysical Research Communications, 2006
• Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1–independent Mechanism
  Molecular Biology of the Cell, 2004
• Simultaneously Targeting Epidermal Growth Factor Receptor Tyrosine Kinase and Cyclooxygenase-2, an Efficient Approach to Inhibition of Squamous Cell Carcinoma of the Head and Neck
  Clinical Cancer Research, 2004
• Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
  The FASEB Journal, 2004
• Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
  Nature Reviews Drug Discovery, 2004
• Hypoxia-Inducible Factor-1 Mediates Activation of Cultured Vascular Endothelial Cells by Inducing Multiple Angiogenic Factors
  Circulation Research, 2003
• Tumorigenesis and the angiogenic switch
  Nature Reviews Cancer, 2003
• VEGF and the quest for tumour angiogenesis factors
  Nature Reviews Cancer, 2002
• Endothelin-1 Induces Vascular Endothelial Growth Factor by Increasing Hypoxia-inducible Factor-1α in Ovarian Carcinoma Cells
  Journal of Biological Chemistry, 2002
• The mRNA Expression of Cyclo-oxygenase-2 (COX-2) and Vascular Endothelial Growth Factor (VEGF) in Human Breast Cancer
  Current Medical Research and Opinion, 2002